Clinical Trial Update: Evaluate SAGE-547 in Participants With Essential Tremor [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating SAGE-547 in participants with essential tremor has completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Tremor

Drugs mentioned

• SAGE-547 (brexanolone)

Snippet

Sponsor: Sage Therapeutics | Conditions: Essential Tremor | Phase 2 | Status: COMPLETED | Results posted: 2022-06-29